Travere Therapeutics (17R) Revenue

2 Followers

Travere Therapeutics Revenue

Travere Therapeutics had a revenue of 169.58M in the quarter ending Jun 30, 2026, with 33.32%. This bring the company's revenue in the last twelve months to 591.33M, Decreased 10.28%. In the fiscal year ending Dec 31, 2025, Travere Therapeutics had annual revenue of 490.73M with 110.45% growth.

Revenue (ttm)

591.33M

Revenue Growth

―

P/S Ratio

10.50

Revenue/Employee

€987,380

Employees

497

Market Cap

€5.15B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	490.73M	257.55M	+110.45%
Dec 31, 2024	233.18M	87.94M	+60.55%
Dec 31, 2023	145.24M	35.78M	+32.69%
Dec 31, 2022	109.46M	-22.38M	-16.97%
Dec 31, 2021	131.84M	-66.48M	-33.52%
Dec 31, 2020	198.32M	22.98M	+13.11%
Dec 31, 2019	175.34M	11.09M	+6.75%
Dec 31, 2018	164.25M	9.31M	+6.01%
Dec 31, 2017	154.94M	―	―